Rutgers Cancer Institute — New Brunswick, New Jersey

Rutgers Cancer Institute is a clinical research site located in New Brunswick, New Jersey, United States 08901.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Rutgers Cancer Institute has participated in 39 clinical trials with 34 currently active.

Therapeutic areas: Colorectal Neoplasms, Stage IV Non-small Cell Lung Cancer, Stage IV Malignant Melanoma.

Sponsors: Janssen Research & Development, LLC, OncoHost Ltd., Rutgers, The State University of New Jersey.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rutgers Cancer Institute?

Rutgers Cancer Institute has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rutgers Cancer Institute conducted?

Rutgers Cancer Institute has 39 clinical trials on record, with 34 currently active. Their work covers Colorectal Neoplasms, Stage IV Non-small Cell Lung Cancer, Stage IV Malignant Melanoma.

Is Rutgers Cancer Institute accredited by Crixeo Health?

Yes — Rutgers Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rutgers Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.